Cargando…

Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer

The objective of the present work was to analyze volatile compounds in alveolar air in patients with squamous cell lung cancer, lung adenocarcinoma or colon cancer, to prepare algorithms able to discriminate such specific pathological conditions. The concentration of 95 volatile compounds was measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Politi, Leonardo, Monasta, Lorenzo, Rigressi, Maria Novella, Princivalle, Andrea, Gonfiotti, Alessandro, Camiciottoli, Gianna, Perbellini, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866040/
https://www.ncbi.nlm.nih.gov/pubmed/33494458
http://dx.doi.org/10.3390/molecules26030550
_version_ 1783647988185300992
author Politi, Leonardo
Monasta, Lorenzo
Rigressi, Maria Novella
Princivalle, Andrea
Gonfiotti, Alessandro
Camiciottoli, Gianna
Perbellini, Luigi
author_facet Politi, Leonardo
Monasta, Lorenzo
Rigressi, Maria Novella
Princivalle, Andrea
Gonfiotti, Alessandro
Camiciottoli, Gianna
Perbellini, Luigi
author_sort Politi, Leonardo
collection PubMed
description The objective of the present work was to analyze volatile compounds in alveolar air in patients with squamous cell lung cancer, lung adenocarcinoma or colon cancer, to prepare algorithms able to discriminate such specific pathological conditions. The concentration of 95 volatile compounds was measured in the alveolar air of 45 control subjects, 36 patients with lung adenocarcinoma, 25 patients with squamous cell lung cancer and 52 patients with colon cancer. Volatile compounds were measured with ion molecule reaction mass spectrometry (IMR-MS). An iterated least absolute shrinkage and selection operator multivariate logistic regression model was used to generate specific algorithms and discriminate control subjects from patients with different kinds of cancer. The final predictive models reached the following performance: by using 11 compounds, patients with lung adenocarcinoma were identified with a sensitivity of 86% and specificity of 84%; nine compounds allowed us to identify patients with lung squamous cell carcinoma with a sensitivity of 88% and specificity of 84%; patients with colon adenocarcinoma could be identified with a sensitivity of 96% and a specificity of 73% using a model comprising 13 volatile compounds. The different alveolar profiles of volatile compounds, obtained from patients with three different kinds of cancer, suggest dissimilar biological–biochemistry conditions; each kind of cancer has probably got a specific alveolar profile.
format Online
Article
Text
id pubmed-7866040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78660402021-02-07 Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer Politi, Leonardo Monasta, Lorenzo Rigressi, Maria Novella Princivalle, Andrea Gonfiotti, Alessandro Camiciottoli, Gianna Perbellini, Luigi Molecules Article The objective of the present work was to analyze volatile compounds in alveolar air in patients with squamous cell lung cancer, lung adenocarcinoma or colon cancer, to prepare algorithms able to discriminate such specific pathological conditions. The concentration of 95 volatile compounds was measured in the alveolar air of 45 control subjects, 36 patients with lung adenocarcinoma, 25 patients with squamous cell lung cancer and 52 patients with colon cancer. Volatile compounds were measured with ion molecule reaction mass spectrometry (IMR-MS). An iterated least absolute shrinkage and selection operator multivariate logistic regression model was used to generate specific algorithms and discriminate control subjects from patients with different kinds of cancer. The final predictive models reached the following performance: by using 11 compounds, patients with lung adenocarcinoma were identified with a sensitivity of 86% and specificity of 84%; nine compounds allowed us to identify patients with lung squamous cell carcinoma with a sensitivity of 88% and specificity of 84%; patients with colon adenocarcinoma could be identified with a sensitivity of 96% and a specificity of 73% using a model comprising 13 volatile compounds. The different alveolar profiles of volatile compounds, obtained from patients with three different kinds of cancer, suggest dissimilar biological–biochemistry conditions; each kind of cancer has probably got a specific alveolar profile. MDPI 2021-01-21 /pmc/articles/PMC7866040/ /pubmed/33494458 http://dx.doi.org/10.3390/molecules26030550 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Politi, Leonardo
Monasta, Lorenzo
Rigressi, Maria Novella
Princivalle, Andrea
Gonfiotti, Alessandro
Camiciottoli, Gianna
Perbellini, Luigi
Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer
title Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer
title_full Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer
title_fullStr Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer
title_full_unstemmed Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer
title_short Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer
title_sort discriminant profiles of volatile compounds in the alveolar air of patients with squamous cell lung cancer, lung adenocarcinoma or colon cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866040/
https://www.ncbi.nlm.nih.gov/pubmed/33494458
http://dx.doi.org/10.3390/molecules26030550
work_keys_str_mv AT politileonardo discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer
AT monastalorenzo discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer
AT rigressimarianovella discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer
AT princivalleandrea discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer
AT gonfiottialessandro discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer
AT camiciottoligianna discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer
AT perbelliniluigi discriminantprofilesofvolatilecompoundsinthealveolarairofpatientswithsquamouscelllungcancerlungadenocarcinomaorcoloncancer